MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #2, January 2017
Plaintiffs have asked the JPML to create a multidistrict litigation docket for claims relating to Stryker’s recalled LFIT V40 femoral head, saying that transfer and consolidation for pre-trial proceedings will “promote the just and efficient conduct of these actions.”
Issue #001, December 2016
A petition was filed late Thursday urging the Judicial Panel on Mutlidistrict Litigation (JPML) to create a centralized docket for more than 100 lawsuits filed by women who claim they developed intracranial hypertension as a result of their use of Bayer’s Mirena birth control device.
A Kentucky woman has sued Takeda Pharmaceuticals USA Inc. in Illinois federal court, claiming that the company’s heartburn drug Dexilant is to blame for her development of chronic kidney disease.
Nearly two dozen federal lawsuits alleging injuries caused by Atrium Medical Corp.’s C-Qur hernia mesh product have been sent to a judge in New Hampshire for coordinated pretrial proceedings.
More than 50 federal lawsuits alleging kidney damage and other injuries caused by the diabetes drug Invokana have been transferred to a judge in New Jersey for coordinated pretrial proceedings.
Plaintiffs in one of four pending nationwide class actions accusing HP Inc. of using software updates to disable HP printers that utilized competitors’ ink cartridges have moved to consolidate the cases in California.
Pfizer Inc. is the latest defendant in the Proton Pump Inhibitor (PPI) personal injury litigation to oppose a recent motion by plaintiffs to create a multidistrict litigation docket in Louisiana for all similar cases filed in federal court.
Johnson & Johnson Takes Aim at 3rd Party Litigation Financing in Response to Plaintiffs’ Steering Committee Bid
Johnson & Johnson has asked the federal judge presiding over the talcum powder MDL to require plaintiffs to disclose whether any third parties — including litigation funding companies — have a contingent monetary interest in the outcome of the cases.
Talcum Powder MDL Court Appoints Lead Counsel, Steering Committee; Orders Designation of State Court Liaison, Defers Weighing in on Funding Concerns
The court overseeing the federal talcum powder multidistrict litigation docket has issued an order outlining the organization of plaintiffs’ counsel, appointing P. Leigh O’Dell of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., and Michelle A. Parfitt of Ashcraft & Gerel, LLP, as co-lead counsel in the litigation.